Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 4,618 CCCC shares, $14.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 4,618 | $14.5K |
| Jul 2, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 3,341 | $14.5K |
| Jun 26, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 62,000 | n/a |
| Apr 3, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 5,370 | $14.5K |
| Jan 5, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 7,513 | $14.5K |
| Oct 3, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 6,740 | $14.5K |
| Jul 2, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 9,609 | $14.5K |
| Jun 20, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 35,500 | n/a |
| Apr 3, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 9,581 | $13.7K |
| Jan 3, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 3,757 | $13.8K |